Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease.

[1]  D. Nelson,et al.  Toll-like Receptors in Pregnancy Disorders and Placental Dysfunction , 2010, Clinical reviews in allergy & immunology.

[2]  P. Menasché,et al.  Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. , 2010, Stem cells and development.

[3]  Q. Shao,et al.  Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis , 2010, Inflammation Research.

[4]  Nicole C. Robb,et al.  RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection , 2010, Cell.

[5]  G. Koh,et al.  Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. , 2010, Blood.

[6]  A. Mobasheri,et al.  Mesenchymal stem cells in regenerative medicine: Opportunities and challenges for articular cartilage and intervertebral disc tissue engineering , 2010, Journal of cellular physiology.

[7]  Dajin Li,et al.  The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. , 2009, Clinical immunology.

[8]  L. Fainboim,et al.  IL-6 trans-signaling and the frequency of CD4+FOXP3+ cells in women with reproductive failure. , 2009, Journal of reproductive immunology.

[9]  S. Akira,et al.  A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA , 2009, Proceedings of the National Academy of Sciences.

[10]  D. Fuchs,et al.  Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. , 2009, Blood.

[11]  D. Sargent,et al.  Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. , 2009, Gastroenterology.

[12]  F. Djouad,et al.  Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? , 2009, Rheumatology.

[13]  Jonathan H. Esensten,et al.  Regulatory T cells as therapeutic targets in rheumatoid arthritis , 2009, Nature Reviews Rheumatology.

[14]  M. Soleimani,et al.  Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial , 2009, European journal of gastroenterology & hepatology.

[15]  Yan Li,et al.  Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4+CD25+ Regulatory T Cells , 2009, PloS one.

[16]  Olivier Boyer,et al.  Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted? , 2009, Rheumatology.

[17]  R. Vonderheide,et al.  Clinical Use of Anti‐CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells , 2009, Annals of the New York Academy of Sciences.

[18]  Min-jung Park,et al.  Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis , 2009, Modern rheumatology.

[19]  H. Reichardt,et al.  ORIGINAL ARTICLE: Impact of Female Sex Hormones on the Maturation and Function of Human Dendritic Cells , 2009, American journal of reproductive immunology.

[20]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[21]  W. Hagopian,et al.  Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. , 2009, Clinical immunology.

[22]  Brian Salmons,et al.  Stem cell therapies: on track but suffer setback. , 2009, Current opinion in molecular therapeutics.

[23]  P. Dutta,et al.  Tolerance to noninherited maternal antigens in mice and humans , 2009, Current opinion in organ transplantation.

[24]  H. Lyerly,et al.  Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression. , 2009, Current molecular medicine.

[25]  B. Beutler,et al.  Sensors of the innate immune system: their mode of action , 2009, Nature Reviews Rheumatology.

[26]  D. von Bubnoff,et al.  Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells1 , 2009, The Journal of Immunology.

[27]  L. Isola,et al.  Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  Guangjie Chen,et al.  Proportional change of CD4+CD25+ regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. , 2009, Fertility and sterility.

[29]  E. Geissler,et al.  Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function. , 2009, Transplantation proceedings.

[30]  R. Sato,et al.  IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance. , 2009, Immunology letters.

[31]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[32]  G. Dryden.  Overview of stem cell therapy for Crohn's disease , 2009, Expert opinion on biological therapy.

[33]  Derick R. Peterson,et al.  Phase II study of a TLR‐9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma , 2009, British journal of haematology.

[34]  W. Fan,et al.  CTLA4Ig gene transfer alleviates abortion in mice by expanding CD4+CD25+ regulatory T cells and inducing indoleamine 2,3-dioxygenase. , 2009, Journal of reproductive immunology.

[35]  Lingyun Sun,et al.  Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans , 2009, Stem cells.

[36]  A. Kudo,et al.  High mobility group box protein-1 in experimental autoimmune uveoretinitis. , 2009, Investigative ophthalmology & visual science.

[37]  D. Sargent,et al.  W1883 Low Intraepithelial CD3+/FOXP3+ Regulatory T-Cell Ratio Predicts Adverse Outcome in Human Colon Carcinomas , 2009 .

[38]  H. Volk,et al.  Human Chorionic Gonadotropin Attracts Regulatory T Cells into the Fetal-Maternal Interface during Early Human Pregnancy1 , 2009, The Journal of Immunology.

[39]  Amit N. Patel,et al.  Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis , 2009, Journal of Translational Medicine.

[40]  P. Tak,et al.  Heat Shock Protein 96 Is Elevated in Rheumatoid Arthritis and Activates Macrophages Primarily via TLR2 Signaling 1 , 2009, The Journal of Immunology.

[41]  S. Ménard,et al.  FOXP3 expression and overall survival in breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Manuel A. González,et al.  Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. , 2009, Arthritis and rheumatism.

[43]  A. Salem,et al.  Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma , 2009, Cancer Immunology, Immunotherapy.

[44]  E. Schwarz,et al.  Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.

[45]  Yuan Luo,et al.  A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis. , 2009, Molecular immunology.

[46]  D. Felsher,et al.  Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down‐modulation , 2009, Hepatology.

[47]  Yifan Dai,et al.  Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. , 2009, Journal of autoimmunity.

[48]  L. Fouillard,et al.  Selected Stro‐1‐enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation , 2009, International journal of laboratory hematology.

[49]  Lingyun Sun,et al.  Transplantation of Human Bone Marrow Mesenchymal Stem Cell Ameliorates the Autoimmune Pathogenesis in MRL/lpr Mice , 2008, Cellular and Molecular Immunology.

[50]  S. Woo,et al.  Mesenchymal Stem Cells Inhibit the Differentiation of CD4+ T Cells into Interleukin-17-Secreting T Cells , 2008, Acta Haematologica.

[51]  T. Jacks,et al.  Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer. , 2008, Cancer research.

[52]  D. Karussis,et al.  The potential use of stem cells in multiple sclerosis: An overview of the preclinical experience , 2008, Clinical Neurology and Neurosurgery.

[53]  N. Mao,et al.  Mesenchymal Stem Cells Alter Migratory Property of T and Dendritic Cells to Delay the Development of Murine Lethal Acute Graft‐Versus‐Host Disease , 2008, Stem cells.

[54]  Lisheng Wang,et al.  High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. , 2008, Stem cells and development.

[55]  N. Perico,et al.  Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1 , 2008, The Journal of Immunology.

[56]  Jianzhu Chen,et al.  Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice , 2008, Proceedings of the National Academy of Sciences.

[57]  S. Morini,et al.  Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. , 2008, European journal of cancer.

[58]  A. Zarnani,et al.  Microenvironment of the feto-maternal interface protects the semiallogenic fetus through its immunomodulatory activity on dendritic cells. , 2008, Fertility and sterility.

[59]  Shimon Sakaguchi,et al.  Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation , 2008, Proceedings of the National Academy of Sciences.

[60]  M. Sayegh,et al.  A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients , 2008, Clinical transplantation.

[61]  M. Yarmush,et al.  Bone Marrow‐Derived Mesenchymal Stem Cells Ameliorate Autoimmune Enteropathy Independently of Regulatory T Cells , 2008, Stem cells.

[62]  Q. Meng,et al.  Involvement of Foxp3‐expressing CD4+ CD25+ regulatory T cells in the development of tolerance induced by transforming growth factor‐β2‐treated antigen‐presenting cells , 2008, Immunology.

[63]  T. Okano,et al.  Novel Cardiac Precursor‐Like Cells from Human Menstrual Blood‐Derived Mesenchymal Cells , 2008, Stem cells.

[64]  T. Ben-Hur,et al.  Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. , 2008, Archives of neurology.

[65]  J. Schweizer,et al.  Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia , 2008, Leukemia.

[66]  G. Leclercq,et al.  Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis , 2008, Annals of the rheumatic diseases.

[67]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[68]  H. Reichardt,et al.  Reproductive Biology and Endocrinology Open Access the Glycoprotein-hormones Activin a and Inhibin a Interfere with Dendritic Cell Maturation , 2022 .

[69]  Kwanghee Kim,et al.  Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells , 2008, Archives of pharmacal research.

[70]  Amit N. Patel,et al.  Multipotent Menstrual Blood Stromal Stem Cells: Isolation, Characterization, and Differentiation , 2008, Cell transplantation.

[71]  Guang-qian Zhou,et al.  SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model , 2008, Brain Research.

[72]  Peizeng Yang,et al.  A penetrating ocular injury can affect the induction of anterior chamber–associated immune deviation , 2008, Molecular vision.

[73]  B. Gharesi-Fard,et al.  ORIGINAL ARTICLE: Effect of Leukocyte Therapy on Tumor Necrosis Factor‐Alpha and Interferon‐Gamma Production in Patients with Recurrent Spontaneous Abortion , 2008, American journal of reproductive immunology.

[74]  J. Gimble,et al.  Multipotential human adipose‐derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo , 2008, Journal of cellular physiology.

[75]  Min-jung Park,et al.  Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model , 2008, Arthritis research & therapy.

[76]  Shing-Hwa Liu,et al.  Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 Diabetes , 2008, PloS one.

[77]  H. Hurwitz,et al.  The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients , 2008, Cancer Immunology, Immunotherapy.

[78]  R. Germain.  Special regulatory T‐cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm , 2008, Immunology.

[79]  N. Rouas-Freiss,et al.  Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.

[80]  Kenichi Tanaka,et al.  Results of Immunotherapy for Patients with Unexplained Primary Recurrent Abortions – Prospective Non‐Randomized Cohort Study , 2007, American journal of reproductive immunology.

[81]  Lars Karlsson,et al.  TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. , 2007, Inflammation & allergy drug targets.

[82]  Ulrich H. von Andrian,et al.  Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues , 2007, Cell.

[83]  Hao Wang,et al.  Endometrial regenerative cells: A novel stem cell population , 2007, Journal of Translational Medicine.

[84]  K. Atkinson,et al.  Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. , 2007, Placenta.

[85]  O. Ringdén,et al.  Immunomodulation by mesenchymal stem cells and clinical experience , 2007, Journal of internal medicine.

[86]  T. Ley,et al.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. , 2007, Immunity.

[87]  S. Lehmann,et al.  Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[88]  W. Weimar,et al.  Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. , 2007, Stem cells and development.

[89]  P. Carmeliet,et al.  NKT Cell-Derived Urokinase-Type Plasminogen Activator Promotes Peripheral Tolerance Associated with Eye1 , 2007, The Journal of Immunology.

[90]  A. Enk,et al.  Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: Role of B7‐H3 expression and antigen presentation , 2007, European journal of immunology.

[91]  C. Darlington.  MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. , 2007, Current opinion in molecular therapeutics.

[92]  H. Lyerly,et al.  CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy , 2007, Expert opinion on biological therapy.

[93]  J. Ryan,et al.  Interferon‐γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells , 2007 .

[94]  M. Nikougoftar,et al.  Immunosuppressive effect of pregnant mouse serum on allostimulatory activity of dendritic cells. , 2007, Journal of reproductive immunology.

[95]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[96]  R. Zhao,et al.  Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. , 2007, Haematologica.

[97]  L. Ortiz,et al.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.

[98]  F. Barry,et al.  IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells , 2007 .

[99]  H. Kiem,et al.  Comparison of Mesenchymal Stem Cells from Different Tissues to Suppress T-Cell Activation , 2007, Cell transplantation.

[100]  Yun-Hoon Choung,et al.  Isolation and characterization of postnatal stem cells from human dental tissues. , 2007, Tissue engineering.

[101]  R. Cancedda,et al.  Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. , 2007, Arthritis and rheumatism.

[102]  Kwanghee Kim,et al.  Auranofin, immunosuppressive drug, inhibits the MHC class I and MHC class II pathway of antigen presentation in dendritic cells (B41) , 2007, The Journal of Immunology.

[103]  P. M. Wang,et al.  Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. , 2007, Transplantation proceedings.

[104]  V. De Rosa,et al.  A key role of leptin in the control of regulatory T cell proliferation. , 2007, Immunity.

[105]  P. Lipsky,et al.  Mesenchymal stromal cells. Nurse-like cells reside in the synovial tissue and bone marrow in rheumatoid arthritis , 2007, Arthritis research & therapy.

[106]  C. Wan,et al.  Concise Review: Multipotent Mesenchymal Stromal Cells in Blood , 2007, Stem cells.

[107]  H. Weiner,et al.  Th3 Cells in Peripheral Tolerance. I. Induction of Foxp3-Positive Regulatory T Cells by Th3 Cells Derived from TGF-β T Cell-Transgenic Mice1 , 2007, The Journal of Immunology.

[108]  M. Joshi,et al.  Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients , 2006, Cancer.

[109]  P. Lewkowicz,et al.  Lipopolysaccharide-Activated CD4+CD25+ T Regulatory Cells Inhibit Neutrophil Function and Promote Their Apoptosis and Death1 , 2006, The Journal of Immunology.

[110]  L. Chatenoud,et al.  Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. , 2006, Immunity.

[111]  David J. Freeman,et al.  Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived Immunosuppressive Molecule IDO through RNA Interference1 , 2006, The Journal of Immunology.

[112]  Y. Wang,et al.  CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[113]  S. Wahl,et al.  TGF‐β: a mobile purveyor of immune privilege , 2006 .

[114]  H. Weiner,et al.  Oral tolerance and TGF-beta-producing cells. , 2006, Inflammation & allergy drug targets.

[115]  Motohiko Suzuki,et al.  Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine , 2006, Arthritis research & therapy.

[116]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[117]  J. Jacobs,et al.  Are Glucocorticoids DMARDs? , 2006, Annals of the New York Academy of Sciences.

[118]  H. Weiner,et al.  Oral Tolerance: Therapeutic Implications for Autoimmune Diseases , 2006, Clinical & developmental immunology.

[119]  L. Joosten,et al.  Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis1 , 2006, The Journal of Immunology.

[120]  Hanns-Ulrich Marschall,et al.  Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.

[121]  K. Steinbrink,et al.  Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[122]  L. Fouillard,et al.  Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. , 2006, Gene expression.

[123]  Min-jung Park,et al.  Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. , 2006, Arthritis and rheumatism.

[124]  J. Blay,et al.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner , 2005, The Journal of experimental medicine.

[125]  R. Gay,et al.  RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. , 2005, Arthritis and rheumatism.

[126]  G. Mancardi,et al.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.

[127]  A. Sette,et al.  Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis , 2005, The Lancet.

[128]  I. Weissman,et al.  Hematopoietic cells maintain hematopoietic fates upon entering the brain , 2005, The Journal of experimental medicine.

[129]  F. Djouad,et al.  Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[130]  K. Stuhlmeier,et al.  The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function , 2005, Arthritis research & therapy.

[131]  C. Fuster,et al.  Cytokine expression and dendritic cell density in melanoma sentinel nodes , 2005, Melanoma research.

[132]  H. Boehmer,et al.  Mechanisms of suppression by suppressor T cells , 2005, Nature Immunology.

[133]  A. Berrebi,et al.  Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha. , 2005, Blood.

[134]  U. Ikeda,et al.  Repair of Infarcted Myocardium Mediated by Transplanted Bone Marrow–Derived CD34+ Stem Cells in a Nonhuman Primate Model , 2005, Stem cells.

[135]  Jung Mogg Kim,et al.  Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. , 2005, International immunology.

[136]  Z. Guan,et al.  The Thymus Plays a Role in Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis , 2004, Annals of the New York Academy of Sciences.

[137]  S. Brix,et al.  Lipopolysaccharide Contamination of β-Lactoglobulin Affects the Immune Response against Intraperitoneally and Orally Administered Antigen , 2004, International Archives of Allergy and Immunology.

[138]  S Gary Firestein,et al.  Kelley's Textbook of Rheumatology , 2004 .

[139]  Yeonseok Chung,et al.  NKT cell ligand α‐galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation , 2004, European journal of immunology.

[140]  H. Naritomi,et al.  Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. , 2004, The Journal of clinical investigation.

[141]  K. Rycerz,et al.  RNA Interference: A Potent Tool for Gene‐Specific Therapeutics , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[142]  J. Bathon,et al.  Etanercept: a clinical review of current and emerging indications , 2004, Expert opinion on pharmacotherapy.

[143]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[144]  T. Whiteside.  Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer? , 2004, Cancer Immunology, Immunotherapy.

[145]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[146]  F. Kudo,et al.  Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. , 2003, International angiology : a journal of the International Union of Angiology.

[147]  D. Munn,et al.  Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma , 2003, Laboratory Investigation.

[148]  T. Ichim,et al.  LF15‐0195 generates tolerogenic dendritic cells by suppression of NF‐κB signaling through inhibition of IKK activity , 2003, Journal of leukocyte biology.

[149]  F. Ruscetti,et al.  Neutralization of Autocrine Transforming Growth Factor‐β in Human Cord Blood CD34+CD38−Lin− Cells Promotes Stem‐Cell‐Factor‐Mediated Erythropoietin‐Independent Early Erythroid Progenitor Development and Reduces Terminal Differentiation , 2003, Stem cells.

[150]  J. V. van Meerwijk,et al.  Oxidative‐stress‐induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules , 2003, European journal of immunology.

[151]  T. Ichim,et al.  Immune Modulation by Silencing IL-12 Production in Dendritic Cells Using Small Interfering RNA12 , 2003, The Journal of Immunology.

[152]  T. Ichim,et al.  Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells. , 2003, Transplant immunology.

[153]  C. Dinarello.  Anti-cytokine therapeutics and infections. , 2003, Vaccine.

[154]  George McNamara,et al.  Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. , 2003, Blood.

[155]  T. Curiel,et al.  Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity , 2003, Nature Medicine.

[156]  T. Ichim,et al.  Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells1 , 2003, Transplantation.

[157]  D. Clark.  Is There Any Evidence for Immunologically Mediated or Immunologically Modifiable Early Pregnancy Failure? , 2003, Journal of Assisted Reproduction and Genetics.

[158]  T. Ichim,et al.  Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance 1 , 2003, The Journal of Immunology.

[159]  L. Chatenoud.  CD3-specific antibody-induced active tolerance: from bench to bedside , 2003, Nature reviews. Immunology.

[160]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[161]  L. Lefrançois,et al.  Cutting Edge: Inflammatory Signals Drive Organ-Specific Autoimmunity to Normally Cross-Tolerizing Endogenous Antigen1 , 2002, The Journal of Immunology.

[162]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[163]  T. Whiteside,et al.  Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[164]  M. Herrmann,et al.  Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation1 , 2002, The Journal of Immunology.

[165]  J. Streilein,et al.  Using Tolerance Induced Via the Anterior Chamber of the Eye to Inhibit Th2-Dependent Pulmonary Pathology1 , 2002, The Journal of Immunology.

[166]  P. Gupta,et al.  Constitutive expression of the Fas receptor and its ligand in adult human bone marrow: a regulatory feedback loop for the homeostatic control of hematopoiesis. , 2002, Blood cells, molecules & diseases.

[167]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[168]  H. Papadaki,et al.  Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. , 2002, Blood.

[169]  Najia Shakoor,et al.  Drug-induced systemic lupus erythematosus associated with etanercept therapy , 2002, The Lancet.

[170]  S. Hwang,et al.  Inhibition of interleukin‐12 production by auranofin, an anti‐rheumatic gold compound, deviates CD4+ T cells from the Th1 to the Th2 pathway , 2001, British journal of pharmacology.

[171]  W. Strober,et al.  Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.

[172]  A. Klein,et al.  Skin filling. Collagen and other injectables of the skin. , 2001, Dermatologic clinics.

[173]  M. Ratajczak,et al.  Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. , 2001, Blood.

[174]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[175]  M. Martelli,et al.  Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. , 2000, Current opinion in immunology.

[176]  D. Carbone,et al.  Clinical significance of defective dendritic cell differentiation in cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[177]  N. Fortunel,et al.  TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. , 2000, Journal of cell science.

[178]  R. Gorczynski,et al.  Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival1 , 2000, The Journal of Immunology.

[179]  T. Whiteside.  Signaling defects in T lymphocytes of patients with malignancy , 1999, Cancer Immunology, Immunotherapy.

[180]  Wei Xu,et al.  In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. , 1999, Transplantation.

[181]  Tomohiro Kato,et al.  Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[182]  R. Gill,et al.  Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent. , 1999, Journal of immunology.

[183]  G. Korbutt,et al.  Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand. , 1998, Transplantation.

[184]  A. Mowat,et al.  Expanding dendritic cells in vivo enhances the induction of oral tolerance. , 1998, Journal of immunology.

[185]  A. Berrebi,et al.  Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. , 1998, Transplantation.

[186]  A. Ziegler,et al.  Delay of Type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial , 1998, Diabetologia.

[187]  E. Simpson,et al.  An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow , 1998, Nature Medicine.

[188]  T. Ochi,et al.  Bone marrow stromal cells contribute to synovial cell proliferation in rats with collagen induced arthritis. , 1996, The Journal of rheumatology.

[189]  Fortner Jg,et al.  Treatment of rheumatoid arthritis by immunization with mononuclear white blood cells: results of a preliminary trial. , 1996 .

[190]  D. Feiglin,et al.  Liposuction fat-fillant implant for breast augmentation and reconstruction , 1995, Aesthetic Plastic Surgery.

[191]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[192]  H. Weiner,et al.  Effects of oral administration of type II collagen on rheumatoid arthritis. , 1993, Science.

[193]  R. North,et al.  Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells , 1993, International journal of cancer.

[194]  P. Emery,et al.  The validity of surrogate markers in rheumatic disease. , 1993, British journal of rheumatology.

[195]  B. Hall,et al.  SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE: V. DEPENDENCE OF CD4+ SUPPRESSOR CELLS ON THE PRESENCE OF ALLOANTIGEN AND CYTOKINES, INCLUDING INTERLEUKIN 21 , 1993, Transplantation.

[196]  R. Zinkernagel,et al.  Vaccination or tolerance to prevent diabetes , 1992, European journal of immunology.

[197]  J. Hatzfeld,et al.  Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides , 1991, The Journal of experimental medicine.

[198]  H. Carp,et al.  Mouse Model for the Treatment of Immune Pregnancy Loss , 1991, American journal of reproductive immunology.

[199]  B. Hall,et al.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action , 1990, The Journal of experimental medicine.

[200]  A. Taggart.  Sulphasalazine in arthritis — an old drug rediscovered , 1987, Clinical Rheumatology.

[201]  J. Niederkorn,et al.  Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. , 1985, Journal of immunology.

[202]  W. Ptak,et al.  Immunological agnosis: a state that derives from T suppressor cell inhibition of antigen-presenting cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[203]  J. David,et al.  Passive transfer by cells of type II collagen-induced arthritis in rats. , 1978, The Journal of clinical investigation.

[204]  A. Kang,et al.  Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.

[205]  P. Medawar,et al.  ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.

[206]  A. Thomson,et al.  Use of rapamycin in the induction of tolerogenic dendritic cells. , 2009, Handbook of experimental pharmacology.

[207]  T. Kitaori.  Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model : Stromal cell-derived factor1/CXCR4のシグナルはマウスモデルの骨修復に際して間葉系幹細胞の骨折部への誘導に必須である , 2009 .

[208]  L. Fouillard,et al.  Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. , 2008, Cellular immunology.

[209]  Zhaohui Zheng,et al.  Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. , 2008, Rheumatology.

[210]  R. Handgretinger,et al.  Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. , 2008, Blood cells, molecules & diseases.

[211]  Jae Kwon Lee,et al.  Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. , 2008, Cellular immunology.

[212]  Y. Li,et al.  The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study , 2008, Leukemia.

[213]  Guangjie Chen,et al.  RECURRENT PREGNANCY LOSS Proportional change of CD4 D CD25 D regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients , 2008 .

[214]  C. Adams,et al.  Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. , 2007, Veterinary therapeutics : research in applied veterinary medicine.

[215]  J. Stein‐Streilein,et al.  Cross talk among cells promoting anterior chamber-associated immune deviation. , 2007, Chemical immunology and allergy.

[216]  O. Ringdén,et al.  Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Commentary , 2006 .

[217]  K. Rycerz,et al.  Induction of RNA interference in dendritic cells , 2004, Immunologic research.

[218]  L. Harrison,et al.  Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans? , 2004, The review of diabetic studies : RDS.

[219]  D. Munn,et al.  Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy , 2001, Nature Immunology.

[220]  R. C. Elder,et al.  Dicyanogold Effects on Lymphokine Production , 1999, Metal-based drugs.

[221]  J. Hatzfeld,et al.  Purification and release from quiescence of umbilical cord blood early progenitors reveal their potential to engraft adults. , 1994, Blood cells.

[222]  H. Weiner,et al.  Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. , 1994, Chemical immunology.

[223]  N. Staines,et al.  Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression. , 1993, Autoimmunity.

[224]  M. Feldmann,et al.  Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.